Monday, January 7, 2019
Allergan CEO says not looking at ‘transformational’ deal
Allergan CEO Brent Saunders said the company is not looking to do a “transformational” deal and that the sale process for its Women’s Health and antibiotics assets is continuing, according to Bloomberg. Saunders also said during an interview that the company plans to submit migraine drug ubrogepant with the FDA “imminently,” according to Bloomberg.
https://thefly.com/landingPageNews.php?id=2844915
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.